ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
Medexus Pharmaceuticals Inc

Medexus Pharmaceuticals Inc (MDP)

2,45
0,32
(15,02%)
Fermé 23 Novembre 10:12PM

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Statistiques et détails clés

Dernier
2,45
Prix Achat
2,28
Prix Vente
2,45
Volume échangé
46 306
2,08 Fourchette du Jour 2,45
1,44 Plage de 52 semaines 3,16
Cap du marché
Clôture Veille
2,13
Ouverture
2,13
Dernière Transaction
400
@
2.45
Dernière heure de transaction
Volume financier
-
VWAP
-
Volume moyen (3 m)
28 111
Actions en circulation
24 458 000
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-281,61
Bénéfice par action (BPA)
-0,01
Chiffre d'affairess
113,05M
Bénéfice net
-214k

À propos de Medexus Pharmaceuticals Inc

Secteur
Pharmaceutical Preparations
Industrie
Blank Checks
Site Web
Siège social
Bolton, Gbr
Fondé
2013
Medexus Pharmaceuticals Inc est coté dans le secteur Pharmaceutical Preparations de la Toronto Stock Exchange avec le ticker MDP. Le dernier cours de clôture d'Medexus Pharmaceuticals était de $2,13. Au cours de la dernière année, les actions de Medexus Pharmaceuticals ont été négociées dans une fourchette de prix de $ 1,44 à $ 3,16.

Medexus Pharmaceuticals compte actuellement 24 458 000 actions en circulation. La capitalisation boursière d'Medexus Pharmaceuticals est de $52,10 million. Medexus Pharmaceuticals a un ratio cours/bénéfice (ratio PE) de -281.61.

MDP Dernières nouvelles

Medexus Pharmaceuticals Announces C$10 Million Bought-Deal Public Offering of Units

TORONTO and CHICAGO, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. ("Medexus" or the "Company") (TSX: MDP) (OTCQX: MEDXF), is pleased to announce that it has entered into an...

Medexus to Participate in the 2023 Bloom Burton & Co. Healthcare Investor Conference

TORONTO and CHICAGO, April 18, 2023 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals (TSX: MDP; OTCQX: MEDXF) is pleased to announce that company management will be participating in the 2023 Bloom...

Medexus Expects Record Revenue for Fiscal Year 2023 and Provides Business Update

TORONTO and CHICAGO, April 11, 2023 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals (TSX: MDP; OTCQX: MEDXF) is pleased to announce preliminary revenue estimates for the company’s fourth fiscal...

Medexus Announces New License Deal for Topical Terbinafine

TORONTO and CHICAGO, March 22, 2023 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals (TSX: MDP; OTCQX: MEDXF) is pleased to announce that the company has secured Canadian rights to commercialize...

Medexus Announces US$58.5 million in New Credit Facilities

TORONTO and CHICAGO, March 08, 2023 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals (TSX: MDP; TSX: MDP.DB; OTCQX: MEDXF) today entered into a new senior secured credit agreement agented by BMO. The...

Medexus to Participate in 35th Annual Roth Conference

TORONTO and CHICAGO, March 06, 2023 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals (TSX: MDP; OTCQX: MEDXF) is pleased to announce that company management will be participating in the 35th Annual...

Medexus Announces Another Record Quarter with Fiscal Q3 2023 Revenue of US$28.7 Million, a 35% Increase Over Fiscal Q3 2022

Results reflect growth across all leading prescription products, demonstrating continued track record of strong overall performance Management to host conference call at 8:00 AM Eastern Time on...

Medexus Welcomes Two New Board Members

Harmony P. Garges MD MPH and Menassie Taddese MBA appointed to Medexus’s board of directors Appointments bolster Medexus board’s medical and financial expertise, particularly in the United States...

Medexus Secures Public Reimbursement for Cuvposa® in Quebec

TORONTO and CHICAGO, Feb. 01, 2023 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals (Medexus) (TSX: MDP) (OTCQX: MEDXF) wishes to inform investors that the company has reached an agreement with the...

Medexus Schedules Third Fiscal Quarter 2023 Conference Call

TORONTO and CHICAGO, Jan. 31, 2023 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals (Medexus) (TSX: MDP) (OTCQX: MEDXF) plans to host a conference call at 8:00 am Eastern Time on Thursday...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10.4421.89054726372.012.452.01492612.14234516CS
4-0.14-5.405405405412.592.61.72400562.14164166CS
120.031.239669421492.422.751.72281112.35035051CS
260.8351.23456790121.622.751.5337752.13955855CS
520.8856.0509554141.573.161.44451521.98463371CS
156-0.63-20.45454545453.083.530.88369402.05718395CS
260-4.93-66.80216802177.387.90.88387032.39589377CS

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
AABAberdeen International Inc
$ 0,065
(18,18%)
226,54k
MDPMedexus Pharmaceuticals Inc
$ 2,45
(15,02%)
46,31k
NCFNorthcliff Resources Ltd
$ 0,04
(14,29%)
5k
SAMStarcore International Mines Ltd
$ 0,16
(14,29%)
200k
GECGlobal Education Communities Corp
$ 0,225
(12,50%)
60k
BNGBengal Energy Ltd
$ 0,005
(-50,00%)
20k
RTGRTG Mining Inc
$ 0,03
(-25,00%)
13k
SMCSulliden Mining Capital Inc
$ 0,015
(-25,00%)
200k
APSAptose Biosciences Inc
$ 0,27
(-20,59%)
346,55k
FLNTFlint Corporation
$ 0,025
(-16,67%)
28k
SUSuncor Energy Inc
$ 58,04
(0,94%)
14,14M
MFCManulife Financial Corporation
$ 45,42
(-0,53%)
9,73M
SLFSun Life Financial Inc
$ 85,54
(-0,23%)
6,19M
BITFBitfarms Ltd
$ 2,96
(3,14%)
6,17M
CNQCanadian Natural Resources Ltd
$ 48,70
(0,83%)
4,91M
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées